RPAM
AUGX

Rhenman & Partners Asset Management’s Augmedix, Inc. Common Stock AUGX Stock Holding History

Rhenman & Partners Asset Management’s Portfolio AUGX Stock Details AUGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,000,000
Closed -$880K – 101
2024
Q2 		$880K Buy
1,000,000
+200,000
+25% +$412K 0.08% 92
2024
Q1 		$3.27M Buy
+800,000
New +$3.58M 0.31% 64

Other funds holding AUGX

RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
OBAM
ODDO BHF Asset Management Paris, France $2.54B AUM 41.83% 1-Year Est. Return
SM
Samjo Management New York $231M AUM 13.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
GCIA
Gabelli & Co Investment Advisers Rye, New York $674M AUM 64.52% 1-Year Est. Return
HIM
HGC Investment Management Toronto, Ontario, Canada $451M AUM 8.78% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Rhenman & Partners Asset Management's AUGX Position: Q3 2024 in Review

Rhenman & Partners Asset Management sold out of Augmedix, Inc. Common Stock (AUGX) in Q3 2024, closing a stake of 1,000,000 shares — an estimated $880K sold.

Rhenman & Partners Asset Management first reported a position in AUGX in Q1 2024 and held it in 2 quarters. The position peaked at $3.27M in Q1 2024. 45 funds tracked by Wall St. Rank hold AUGX as of Q3 2024.

  • Rhenman & Partners Asset Management reported no remaining Augmedix, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Rhenman & Partners Asset Management sold 1,000,000 Augmedix, Inc. Common Stock shares in Q3 2024, an estimated $880K.
  • Rhenman & Partners Asset Management first reported a position in Augmedix, Inc. Common Stock in Q1 2024 and held it in 2 quarters.
  • Rhenman & Partners Asset Management's Augmedix, Inc. Common Stock position peaked at $3.27M in Q1 2024.
  • 45 funds tracked by Wall St. Rank held Augmedix, Inc. Common Stock as of Q3 2024.

Based on Rhenman & Partners Asset Management's 13F filing for Q3 2024, filed 13 Nov 2024.